Doctors need reliable tests to diagnose and treat patients. Alinity is a group of next-gen diagnostic instruments helping efficiently & flexibly improve care.
Imagine that you woke up this morning with chest pain – a pain that you've never felt before. Concerned and scared, you quickly head to the emergency room at your local hospital, where you're given a variety of tests and asked dozens of questions.
These tests and questions are all meant to help you and your doctor figure out what you're experiencing and how to respond to it. Speed and accuracy matter. If you're not feeling well, your doctor needs reliable information to inform the diagnosis, monitoring and treatment of whatever condition you may have. In some cases, this information could mean the difference between life and death.
Did you know that almost three quarters of healthcare decisions are influenced by diagnostic testing? This includes everything from diagnosing diseases and infections to testing and ensuring the safety of the blood supply. In some cases, diagnostic testing can actually identify molecular biomarkers that help personalize treatment.
For patients entering the emergency room, doctor’s office or any setting where care is delivered, getting the right test at the right time is critical. There is no room for lengthy waiting times or errors with results.
Changing to meet new diagnostic demands
At the same time behind the scenes, a lot of factors are changing the dynamics for diagnostic testing, including rising global testing volumes due to an aging population, the growing management of chronic diseases and increased access to care. Health systems are also facing pressures to perform testing as efficiently as possible with limited staff and space while also reducing costs.
To help meet these challenges, Abbott's research and development teams engaged with thousands of clinicians, scientists, lab technicians and healthcare executives to create Alinity™, a family of next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics. The Alinity family of diagnostic instruments has been designed to offer more efficiency, flexibility and confidence, ultimately leading to better patient care.
Want to learn more about diagnostics? Check out these resources:
Please note: The Alinity suite of instruments is currently in development. Pending appropriate regulatory approvals, Abbott expects launches to begin later this year and continue into 2017 and 2018.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.